Related Experiment Video
Updated: Sep 10, 2025

04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
20.2K
Development of a conceptual model of early systemic sclerosis (scleroderma)
William R Lenderking1,2, Mary Kathleen Ladd3, Nicola Barnes4
1PPD Evidera Patient-Centered Research, Thermo Fisher Scientific, Waltham, MA, USA.
Orphanet Journal of Rare Diseases
|August 20, 2025
Summary
This study developed a conceptual model for Systemic Sclerosis (SSc) by exploring patient experiences. The model captures diverse symptoms across both limited cutaneous SSc (lcSSc) and diffuse cutaneous SSc (dcSSc) subtypes.
Area of Science:
- Rheumatology
- Medical Sociology
- Patient-Reported Outcomes
Background:
- Systemic Sclerosis (SSc) is a rare, heterogeneous connective tissue disorder with limited cutaneous (lcSSc) and diffuse cutaneous (dcSSc) subtypes.
- Existing models lack comprehensive representation of the diverse patient experiences in SSc.
- A robust conceptual model is crucial for advancing outcome measurement strategies in SSc research.
Purpose of the Study:
- To identify and conceptualize key SSc disease symptoms and experiences.
- To develop a comprehensive conceptual model of SSc symptoms that reflects patient heterogeneity.
- To support the development of measurement instruments for SSc clinical trials.
Main Methods:
- A targeted literature review identified concepts for diffuse cutaneous SSc (dcSSc).
- Semi-structured concept elicitation interviews were conducted with 44 adult patients with lcSSc and dcSSc.
- A preliminary dcSSc symptom model was refined into a final conceptual SSc symptoms model based on interview data.
Main Results:
- 112 unique symptoms across 13 domains were reported by patients, with 26 new to the literature.
- Hand and skin symptoms were universal; gastrointestinal and pain symptoms were highly prevalent (>95%).
- Despite subtype differences, significant overlap in reported symptoms, including skin fibrosis and hand issues, supports a unified model.
Conclusions:
- The developed conceptual model effectively captures the heterogeneous symptoms and lived experiences of patients with Systemic Sclerosis.
- The model encompasses both lcSSc and dcSSc subtypes, providing a unified framework.
- This model can guide the selection or creation of instruments for measuring patient experiences in clinical trials.

